Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -2.83% | +1.98% | -22.56% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.56% | 33.16M | |
-26.08% | 16.09B | |
-40.92% | 2.9B | |
+23.88% | 1.97B | |
-9.90% | 1.53B | |
+29.92% | 1.34B | |
-17.38% | 953M | |
-29.23% | 817M | |
+2.58% | 807M | |
-22.68% | 635M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Earnings Flash (CODX) CO-DIAGNOSTICS Reports Q3 Revenue $5.1M